Radiopharmaceutical imaging products for nuclear medicine use in the department of radiology at walter reed national military medical center

Ended Awarded Last action

Contract number
HT001422F0099
Awardee
Awarding agency
Obligated
$141,500

Award facts

Contract value 100% obligated
$141,500.14 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 -$7,519
Other Administrative Action P00001 $0
Original award $149,019

About this award

This is a firm fixed price delivery order awarded by the Defense Health Agency to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceutical imaging products for nuclear medicine use at the Walter Reed National Military Medical Center. The contract is issued against Lantheus' General Services Administration (GSA) Pharmaceutical and Drugs Schedule contract and has a potential value of $141,500.14. Lantheus Medical Imaging is a subsidiary of Lantheus Holdings, Inc. and is a manufacturer of diagnostic medical imaging agents and products. The company has a history of providing nuclear medicine equipment, contrast media, and specialized pharmaceuticals to support medical imaging and healthcare programs at military and Department of Veterans Affairs treatment facilities through prime federal contracts. This award does not have a set-aside designation.

Quick answers

Who was awarded contract HT001422F0099?

HT001422F0099 was awarded to Lantheus Medical Imaging, Inc. by Defense Health Agency (Department of Defense) on May 5, 2022.

How much is contract HT001422F0099 worth?

The government has obligated $141,500 on HT001422F0099.

Is contract HT001422F0099 an order under another contract?

Yes. HT001422F0099 is a delivery order under 36F79718D0402, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract HT001422F0099 competed?

The extent of competition for HT001422F0099 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award